Raise your voice: 2023 Diversity, Equity & Inclusion (DE&I) Report
One Sanofi. Creating an equitable world, in and beyond the workplace. Bringing the best of our whole selves to work every day. We’re raising our voices to support our colleagues, our friends and families, and the communities where we work. We’re raising our voices to support innovation, as diverse perspectives fuel creativity and problem-solving.
A Million Conversations: Rebuilding Trust in Healthcare
By deploying our expertise, our global networks, and a €50M investment, we're empowering people from marginalized communities to speak directly to the healthcare industry. Because it's time we all listened.
Disability Inclusion in Action
At Sanofi, we are committed to accessibility and disability inclusion through a holistic and best-in-class approach.
Unleashing Our Potential
Our DE&I Board: First of Its Kind in Pharma
Our board includes external experts who work alongside members of our Executive Committee and employee resource groups (ERGs) to shape and drive our DE&I strategy.
Representative Leadership
Leadership that reflects our diversity is a source of strength. By 2025, 50% of our senior leaders and 40% of our executives will be women.
Pay Equity
In 2021 we launched a Global Pay Equity Action Plan to track and reinforce practices to promote parity.
Employee Resource Groups (ERGs): Valued Partners in Driving Culture Change
Growth Opportunities
Our employees are empowered to drive their career. We’re transparent about leadership development, and use AI to match people with mentoring, learning, short-term assignments, and job opportunities.
Life That Works
Our global flexible work and 14+ weeks of gender-neutral, paid parental leave for all employees help us achieve greater equity.
Accessible Workplaces
By 2025, our physical spaces, digital technologies, and ways of working will be fully accessible, helping all employees thrive.
Beyond the Workplace
Supplier
Clinical Trials
We partner with marginalized groups to overcome barriers, make clinical trials more accessible, and build an equitable future of medicine